This suggests that these metabolites reflect metabolic integrity of cells (see SA8 for further discussion)
a supervising physician must confirm that injectable therapy is appropriate before treatment begins
Are Intranasal Drugs the Future for ME/CFS and Fibromyalgia
These promising results warrant future studies examining the effect of these compounds on motor dysfunction and other primary outcomes in ALS patients (Chico et al., 2018)
The plan might include gradually de-escalating the medication dose, considering alternative medications, intensified lifestyle support and more frequent check-ins
Summary Keywords glucagon-like peptide-1 receptor, Alzheimers disease, diabetes mellitus, insulin resistance, neuroinflammation Citation Li S, Huang N, Wang M, Huang W, Shi J, Luo Y and Huang J (2025) GLP-1R as a potential link between diabetes and Alzheimers disease